Market Overview:
The global non-invasive neuromodulation device market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market was valued at US$ 2,362.5 Mn in 2017 and is projected to reach US$ 7,023.9 Mn by 2030. The growth of the global non-invasive neuromodulation device market can be attributed to factors such as rising prevalence of neurological disorders, increasing demand for minimally invasive therapies, and technological advancements in neuromodulation devices. However, high cost of treatment and lack of reimbursement are some factors that are restraining the growth of this market. Based on type, the global non-invasive neuromodulation device market is segmented into transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcranial pulsed current stimulation (tPCS), transcranial random noise stimulation (tRNS), electroconvulsive therapy (ECT), and others). tDCS held the largest share in 2017 owing to its low cost and easy availability compared with other types of devices available in the market.
Product Definition:
Non-invasive neuromodulation devices are used to stimulate the brain without surgery. This type of device is important because it can be used to treat a variety of conditions without any risk of damage to the brain.
Transcranial Direct Current Stimulation (tDCS):
tDCS is an non-invasive technique that delivers a constant current of electricity to the brain through the scalp. The current is targeted towards specific areas of the brain which in turn modifies and improves certain functions. This technology has gained huge popularity over recent years as it helps in treating various neurological disorders such as depression, chronic pain, stroke rehabilitation and Alzheimer’s disease by modifying abnormal neural activity.
Transcranial Alternating Current Stimulation (tACS):
tACS is a non-invasive neuromodulation technology that helps in treating neurological and psychiatric disorders by altering the brain’s electrical activity. It also helps in improving symptoms of depression, anxiety, and other related conditions. The device uses an electric current to stimulate or inhibit neural activity inside the brain. This modality can be used for both chronic as well as acute treatment of several neurological diseases with few side effects associated with it.
Application Insights:
Neuromodulation devices find wide applications in clinics and hospitals as well as in other application areas such as at-home care. The others segment, which includes surgical procedures, is expected to witness the fastest growth during the forecast period owing to an increase in the adoption of these devices for treating depression. According to a study published by World Health Organization (WHO) in April 2016, around half of all mental disorders are treatable with non-invasive methods. Thus, increasing number of patients suffering from various mental disorders are opting for these devices due to their effectiveness and low cost over conventional treatment options such as medication or surgery.
The hospital segment held around 69% market share in 2017 owing to high usage rate of neuromodulation device across epilepsy surgeries especially secondarily generalized epilepsies where seizures occur despite antiepileptic drug therapy or normal brain imaging studies.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing cases of neurological disorders, rising adoption of technologically advanced devices, and growing awareness among individuals about available treatment options. Moreover, presence of well-established healthcare facilities and high purchasing power of consumers are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure & availability of treatment procedures with low cost in countries like India & China as compared to developed nations like U.S., Europe & Australia for instance; Japan costs around USD X for an ECT device while U.S costs around USD X for an electroconvulsive therapy (ECT) machine which has a higher efficacy rate than other expensive devices used in U S or European countries).
Growth Factors:
- Increasing demand for non-invasive neuromodulation devices due to rising prevalence of neurological disorders.
- Growing awareness about the benefits of non-invasive neuromodulation devices among patients and healthcare professionals.
- Technological advancements in non-invasive neuromodulation devices that offer better treatment outcomes.
- Rising number of clinical studies on the efficacy and safety of non-invasive neuromodulation devices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-invasive Neuromodulation Device Market Research Report
By Type
Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Pulsed Current Stimulation (tPCS), Transcranial Random Noise Stimulation (tRNS), Electroconvulsive therapy (ECT), Others
By Application
Hospital, Clinic, Others
By Companies
Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare, Shenzhen Yingchi Technology, Shenzhen Hanix United, Shanghai Qiankang Medical Care Company, TCT Research, EB Neuro SpA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Non-invasive Neuromodulation Device Market Report Segments:
The global Non-invasive Neuromodulation Device market is segmented on the basis of:
Types
Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Pulsed Current Stimulation (tPCS), Transcranial Random Noise Stimulation (tRNS), Electroconvulsive therapy (ECT), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Neuroelectrics
- Magstim
- NeuroCare Group
- Soterix Medical
- Newronika
- Rogue Resolutions
- Medtronic
- Philips Healthcare
- Shenzhen Yingchi Technology
- Shenzhen Hanix United
- Shanghai Qiankang Medical Care Company
- TCT Research
- EB Neuro SpA
Highlights of The Non-invasive Neuromodulation Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Pulsed Current Stimulation (tPCS)
- Transcranial Random Noise Stimulation (tRNS)
- Electroconvulsive therapy (ECT)
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-invasive Neuromodulation Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-invasive neuromodulation device is a medical device that uses electrical stimulation to treat conditions such as pain, epilepsy, and depression.
Some of the key players operating in the non-invasive neuromodulation device market are Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare, Shenzhen Yingchi Technology, Shenzhen Hanix United, Shanghai Qiankang Medical Care Company, TCT Research, EB Neuro SpA.
The non-invasive neuromodulation device market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-invasive Neuromodulation Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-invasive Neuromodulation Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-invasive Neuromodulation Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-invasive Neuromodulation Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-invasive Neuromodulation Device Market Size & Forecast, 2018-2028
4.5.1 Non-invasive Neuromodulation Device Market Size and Y-o-Y Growth
4.5.2 Non-invasive Neuromodulation Device Market Absolute $ Opportunity
Chapter 5 Global Non-invasive Neuromodulation Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Non-invasive Neuromodulation Device Market Size Forecast by Type
5.2.1 Transcranial Direct Current Stimulation (tDCS)
5.2.2 Transcranial Alternating Current Stimulation (tACS)
5.2.3 Transcranial Pulsed Current Stimulation (tPCS)
5.2.4 Transcranial Random Noise Stimulation (tRNS)
5.2.5 Electroconvulsive therapy (ECT)
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Non-invasive Neuromodulation Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Non-invasive Neuromodulation Device Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-invasive Neuromodulation Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-invasive Neuromodulation Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Non-invasive Neuromodulation Device Analysis and Forecast
9.1 Introduction
9.2 North America Non-invasive Neuromodulation Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Non-invasive Neuromodulation Device Market Size Forecast by Type
9.6.1 Transcranial Direct Current Stimulation (tDCS)
9.6.2 Transcranial Alternating Current Stimulation (tACS)
9.6.3 Transcranial Pulsed Current Stimulation (tPCS)
9.6.4 Transcranial Random Noise Stimulation (tRNS)
9.6.5 Electroconvulsive therapy (ECT)
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Non-invasive Neuromodulation Device Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Non-invasive Neuromodulation Device Analysis and Forecast
10.1 Introduction
10.2 Europe Non-invasive Neuromodulation Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Non-invasive Neuromodulation Device Market Size Forecast by Type
10.6.1 Transcranial Direct Current Stimulation (tDCS)
10.6.2 Transcranial Alternating Current Stimulation (tACS)
10.6.3 Transcranial Pulsed Current Stimulation (tPCS)
10.6.4 Transcranial Random Noise Stimulation (tRNS)
10.6.5 Electroconvulsive therapy (ECT)
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Non-invasive Neuromodulation Device Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Non-invasive Neuromodulation Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Non-invasive Neuromodulation Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Non-invasive Neuromodulation Device Market Size Forecast by Type
11.6.1 Transcranial Direct Current Stimulation (tDCS)
11.6.2 Transcranial Alternating Current Stimulation (tACS)
11.6.3 Transcranial Pulsed Current Stimulation (tPCS)
11.6.4 Transcranial Random Noise Stimulation (tRNS)
11.6.5 Electroconvulsive therapy (ECT)
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Non-invasive Neuromodulation Device Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Non-invasive Neuromodulation Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Non-invasive Neuromodulation Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Non-invasive Neuromodulation Device Market Size Forecast by Type
12.6.1 Transcranial Direct Current Stimulation (tDCS)
12.6.2 Transcranial Alternating Current Stimulation (tACS)
12.6.3 Transcranial Pulsed Current Stimulation (tPCS)
12.6.4 Transcranial Random Noise Stimulation (tRNS)
12.6.5 Electroconvulsive therapy (ECT)
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Non-invasive Neuromodulation Device Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Non-invasive Neuromodulation Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Non-invasive Neuromodulation Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Non-invasive Neuromodulation Device Market Size Forecast by Type
13.6.1 Transcranial Direct Current Stimulation (tDCS)
13.6.2 Transcranial Alternating Current Stimulation (tACS)
13.6.3 Transcranial Pulsed Current Stimulation (tPCS)
13.6.4 Transcranial Random Noise Stimulation (tRNS)
13.6.5 Electroconvulsive therapy (ECT)
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Non-invasive Neuromodulation Device Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-invasive Neuromodulation Device Market: Competitive Dashboard
14.2 Global Non-invasive Neuromodulation Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Neuroelectrics
14.3.2 Magstim
14.3.3 NeuroCare Group
14.3.4 Soterix Medical
14.3.5 Newronika
14.3.6 Rogue Resolutions
14.3.7 Medtronic
14.3.8 Philips Healthcare
14.3.9 Shenzhen Yingchi Technology
14.3.10 Shenzhen Hanix United
14.3.11 Shanghai Qiankang Medical Care Company
14.3.12 TCT Research
14.3.13 EB Neuro SpA
